Goverdhan Vavilala, PhD
Dr. Vavilala is co-founder and CEO from January 2008. Dr. Vavilala is an accomplished chemist with more than 10 years of experience in organic and medicinal chemistry. He contributed to the development of IGF-1R inhibitors during his employment at CRL, San Diego, CA. He has a proven track record of success in project management in medicinal chemistry, hit-to-follow libraries and custom synthesis. Before his employment at CRL, he was a postdoctoral fellow in Prof. Eschenmoser group, The Scripps Research Institute, La Jolla, CA. He received his PhD in organic chemistry from Indian Institute of Chemical Technology, Hyderabad, India. Dr. Vavilala, to his credit published more than 20 publications and patents in international journals.
Gautam Patel, PhD
Dr. Patel is working as Senior Scientist from March 2009. Dr. Patel is an accomplished chemist with more than 10 years of experience in organic chemistry. He contributed to the development of API's and intermediates (Atavagone, Telmisartan, Pramipexole, Valsartan etc.) during his employment at USV Limted, Mumbai, India. He has a proven track record of success in delivering the projects in medicinal chemistry and custom synthesis. He received his PhD in organic chemistry from Saurashtra University, Rajkot, India. Dr. Patel, to his credit published more than 10 publications and patents in international journals.
James Schomann, MBA
Mr. James is working as Vice-president, Business Development from 2017, having more than 30 years of experience sales and marketing of BA/BE studies of Genercis, 505B2 and NCE's. His previous employment include Sannova Analytical, Frontage Laborories, GSK and few other clinical companies.